Your browser doesn't support javascript.
loading
A phase 1/2 of a combination of cetuximab and taxane for "triple negative" breast cancer patients.
Nechushtan, Hovav; Vainer, Gilad; Stainberg, Hana; Salmon, Asher Y; Hamburger, Tamar; Peretz, Tamar.
Afiliación
  • Nechushtan H; Oncology Dept., Hadassah Hebrew University Medical Center, Israel. Electronic address: hovavnech@hadassah.org.il.
  • Vainer G; Pathology Dept., Hadassah Hebrew University Medical Center, Israel.
  • Stainberg H; Oncology Dept., Hadassah Hebrew University Medical Center, Israel.
  • Salmon AY; Oncology Dept., Hadassah Hebrew University Medical Center, Israel.
  • Hamburger T; Oncology Dept., Hadassah Hebrew University Medical Center, Israel.
  • Peretz T; Oncology Dept., Hadassah Hebrew University Medical Center, Israel.
Breast ; 23(4): 435-8, 2014 Aug.
Article en En | MEDLINE | ID: mdl-24836394
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de la Mama Triple Negativas Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2014 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de la Mama Triple Negativas Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2014 Tipo del documento: Article